Methadone and Buprenorphine/Naloxone Perform Comparably in Rural Programs
This retrospective rural cohort suggests that site-level factors and treatment duration, not medication choice, drive opioid-use and retention outcomes in community-based programs.
📅 Journal publication: Sep 2026·Last updated: Oct 6, 2026
methadonebuprenorphine/naloxoneopioid use disorderMOUDopioid agonist treatmentrural healthretrospective cohorttreatment retentionurine toxicologyBehavioral Health / Addiction Medicine
Background Information
Methadone and buprenorphine/naloxone show similar efficacy in rural OUD treatment.
Understanding the effectiveness of methadone versus buprenorphine/naloxone in rural settings aids in improving treatment strategies for opioid use disorder. Both medications showed similar effectiveness in reducing opioid use and retaining patients over a year, with clinic site impacting outcomes. This study supports using both methadone and buprenorphine/naloxone in rural areas, highlighting site-specific factors over medication type. Methadone and buprenorphine/naloxone are equally effective in rural OUD treatment programs.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:MacCamy A, Khairy L, Wasser T, Gill G, Kenefick L, Schmidt A, Akana N, Hall L, Kwon K, Limberg N, Kirk-Lewis K, Lewis M, Owen M, McPherson SM, Miguel AQ
Citation:MacCamy A, Khairy L, Wasser T, et al. Methadone Versus Buprenorphine/Naloxone: Treatment Outcome Differences Among Individuals Receiving Medications for Opioid Use Disorders in Rural Treatment Settings-A 1-Year Retrospective Cohort Study. The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association. 2026;42(4):e70219. doi:10.1111/jrh.70219